Cargando…
A European multicentre and open-label controlled randomized trial to evaluate the efficacy of Sequential treatment with TAcrolimus–Rituximab versus steroids plus cyclophosphamide in patients with primary MEmbranous Nephropathy: the STARMEN study
BACKGROUND: Patients with primary membranous nephropathy (MN) and persistent nephrotic syndrome have a high risk of progression to end-stage renal disease. The Ponticelli protocol (steroids with alkylating agents) is the most effective immunosuppressive therapy for this condition, but it has severe...
Autores principales: | Rojas-Rivera, Jorge, Fernández-Juárez, Gema, Ortiz, Alberto, Hofstra, Julia, Gesualdo, Loreto, Tesar, Vladimir, Wetzels, Jack, Segarra, Alfons, Egido, Jesus, Praga, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581392/ https://www.ncbi.nlm.nih.gov/pubmed/26413273 http://dx.doi.org/10.1093/ckj/sfv075 |
Ejemplares similares
-
Rapidly progressive IgA nephropathy: a form of vasculitis or a complement-mediated disease?
por: Rojas-Rivera, Jorge, et al.
Publicado: (2015) -
Rituximab versus steroids and cyclophosphamide for the treatment of primary membranous nephropathy: protocol of a pilot randomised controlled trial
por: Scolari, Francesco, et al.
Publicado: (2019) -
Chapter 7: Idiopathic membranous nephropathy
Publicado: (2012) -
Chapter 10: Immunoglobulin A nephropathy
Publicado: (2012) -
Ambulatory blood pressure and tubulointerstitial injury in patients with IgA nephropathy
por: Haruhara, Kotaro, et al.
Publicado: (2015)